Literature DB >> 125100

Correlation between the inhibition of the acto-heavy meromyosin ATPase and the binding of tropomyosin to F-actin: effects of Mg2+, KCl, troponin I, and troponin C.

B L Eaton, D R Kominz, E Eisenberg.   

Abstract

When stoichiometric amounts of tropomyosin (TM) are bound to F-actin in the presence of 2 mM ATP, the MG2+-activated acto-heavy meromyosin (HMM) ATPase is inhibited by about 60% in 5 mM MgCl2-30 mM KCl. If the concentration of MgCl2 is reduced to 1 mM, the inhibition disappears because TM no longer binds to F-actin. Increasing the concentration of KCl to 100 mM restores both the binding and the inhibition. Thus, the binding of TM alone to F-actin causes significant inhibition of the ATPase provided that the HMM is saturated with ATP. (When the HMM is not saturated, TM activates the ATPase). When TM alone can bind stoichiometrically to F-actin, addition of troponin I (TN-I) increases the inhibition from 60% to about 85%, but the TM binding to F-actin is not affected. Under conditions such that TM alone neither inhibits the acto-HMM ATPase nor binds to F-actin, the inhibition caused by TN-I plus TM still approaches 100%. Direct binding studies under these conditions show that TN-I induces binding between TM and F-actin. A dual role for TN-I is proposed: first, TN-I can induce TM to bind to F-actin, causing inhibition of the ATPase; and second, TN-I can itself enhance the inhibition of the ATPase in a cooperative manner. The addition of TN-C in the absence of CA2+ has only a limited effect on the first role, but seems to be able to block completely the cooperative inhibition caused by TN-I such that the residual inhibition is a function only of the TM which remains bound.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 125100     DOI: 10.1021/bi00683a025

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  25 in total

1.  Tropomyosin positions in regulated thin filaments revealed by cryoelectron microscopy.

Authors:  C Xu; R Craig; L Tobacman; R Horowitz; W Lehman
Journal:  Biophys J       Date:  1999-08       Impact factor: 4.033

2.  Tropomyosin directly modulates actomyosin mechanical performance at the level of a single actin filament.

Authors:  P VanBuren; K A Palmiter; D M Warshaw
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

Review 3.  Troponin I: inhibitor or facilitator.

Authors:  S V Perry
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

Review 4.  Vertebrate tropomyosin: distribution, properties and function.

Authors:  S V Perry
Journal:  J Muscle Res Cell Motil       Date:  2001       Impact factor: 2.698

5.  Effects of deletion of tropomyosin overlap on regulated actomyosin subfragment 1 ATPase.

Authors:  D H Heeley; L B Smillie; E M Lohmeier-Vogel
Journal:  Biochem J       Date:  1989-03-15       Impact factor: 3.857

Review 6.  Gestalt-binding of tropomyosin to actin filaments.

Authors:  Kenneth C Holmes; William Lehman
Journal:  J Muscle Res Cell Motil       Date:  2008-12-31       Impact factor: 2.698

7.  Tropomyosin position on F-actin revealed by EM reconstruction and computational chemistry.

Authors:  Xiaochuan Edward Li; Larry S Tobacman; Ji Young Mun; Roger Craig; Stefan Fischer; William Lehman
Journal:  Biophys J       Date:  2011-02-16       Impact factor: 4.033

8.  Direct observation of tropomyosin binding to actin filaments.

Authors:  William M Schmidt; William Lehman; Jeffrey R Moore
Journal:  Cytoskeleton (Hoboken)       Date:  2015-06-30

Review 9.  There is more than one way to model an elephant. Experiment-driven modeling of the actin cytoskeleton.

Authors:  Jonathon A Ditlev; Bruce J Mayer; Leslie M Loew
Journal:  Biophys J       Date:  2013-02-05       Impact factor: 4.033

10.  Combinatorial effects of double cardiomyopathy mutant alleles in rodent myocytes: a predictive cellular model of myofilament dysregulation in disease.

Authors:  Jennifer Davis; Joseph M Metzger
Journal:  PLoS One       Date:  2010-02-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.